HCID 178422553, Verbindung → HCID 178422554, Verbindung
Reaktionsgleichung
[F:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[CH2:7][CH:6]([CH2:11][NH:12][C@@H:13]1[CH2:18][CH2:17][C@H:16]([N:19]3[C:23]4[CH:24]=[CH:25][C:26]([CH3:28])=[CH:27][C:22]=4[N:21]=[C:20]3[C:29]([OH:32])([CH3:31])[CH3:30])[CH2:15][CH2:14]1)[CH2:5]2>C1CCCCC1>[F:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[CH2:7][CH:6]([CH2:11][NH:12][C@H:13]1[CH2:18][CH2:17][C@H:16]([N:19]3[C:23]4[CH:24]=[CH:25][C:26]([CH3:28])=[CH:27][C:22]=4[N:21]=[C:20]3[C:29]([OH:32])([CH3:30])[CH3:31])[CH2:15][CH2:14]1)[CH2:5]2Komponenten
3
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
This compound was isolated as the second and more polar product in the preparation of cis-2-(1-{4-[(5-fluoro-indan-2-ylmethyl)-amino]-cyclohexyl}-5-methyl-1H-benzoimidazol-2-yl)-propan-2-ol. The analysis of the 1H-NMR confirmed the trans-conformation of the cyclohexane. LC-MS showed a single peak, C27H34FN3O (m/e) calcd 435.2686, obsd 436.3 (M+H).
Aufarbeitung
- customThis compound was isolated as the second and more polar product